High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer
- 1 February 2003
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (3) , 346-352
- https://doi.org/10.1016/s0959-8049(02)00662-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study.Journal of Clinical Oncology, 1996
- Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.Journal of Clinical Oncology, 1995
- Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1994
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Fluorouracil: biochemistry and pharmacology.Journal of Clinical Oncology, 1988
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982
- Synergistic effect of 5-fluorouracil and N-(phosphonacetyl)-l-aspartate on cell growth and ribonucleic acid synthesis in a human mammary carcinomaBiochemical Pharmacology, 1981
- Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation.Proceedings of the National Academy of Sciences, 1980
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958